Lung Transplantation and the Era of the Sensitized Patient.

Loading...
Thumbnail Image

Date

2021-01

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

23
views
19
downloads

Citation Stats

Abstract

Long term outcomes in lung transplant are limited by the development of chronic lung allograft dysfunction (CLAD). Within the past several decades, antibody-mediated rejection (AMR) has been recognized as a risk factor for CLAD. The presence of HLA antibodies in lung transplant candidates, "sensitized patients" may predispose patients to AMR, CLAD, and higher mortality after transplant. This review will discuss issues surrounding the sensitized patient, including mechanisms of sensitization, implications within lung transplant, and management strategies.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.3389/fimmu.2021.689420

Publication Info

Young, Katherine A, Hakim A Ali, Kristi J Beermann, John M Reynolds and Laurie D Snyder (2021). Lung Transplantation and the Era of the Sensitized Patient. Frontiers in immunology, 12. p. 689420. 10.3389/fimmu.2021.689420 Retrieved from https://hdl.handle.net/10161/26148.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Young

Katherine Young

Assistant Professor of Medicine
Ali

Hakim Azfar Ali

Associate Professor of Medicine
Reynolds

John Michael Reynolds

Professor of Medicine
Snyder

Laurie D. Snyder

Professor of Medicine

Advanced lung disease, lung transplantation, interstitial lung disease, immune monitoring


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.